The M1 matrix protein controls the filamentous phenotype of influenza A virus

Virology

Volumn 321, Issue 1, 2004, Pages 144-153

  Elleman, C J ^a   Barclay, W S ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Filament; Influenza; Reverse genetics

Indexed keywords

MATRIX PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; INFLUENZA VIRUS A; INTERMEDIATE FILAMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SPECIES COMPARISON; VIRUS ISOLATION; VIRUS RECOMBINANT; VIRUS RECOMBINATION; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; DOGS; FLUORESCENT ANTIBODY TECHNIQUE; INFLUENZA A VIRUS; MICROSCOPY, ELECTRON, SCANNING; MUTATION; PHENOTYPE; VIRAL MATRIX PROTEINS; VIRUS ASSEMBLY;

INFLUENZA A VIRUS; VICTORIA;

EID: 1642274781     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.12.009     Document Type: Article

References (28)

1. Boom R., Sol C.J., Salimans M.M., Jansen C.L., van Dillen P.M.W., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:1990;495-503.
2. Bourmakina S.V., Garcia-Sastre A. Reverse genetics studies on the filamentous morphology of influenza A virus. J. Gen. Virol. 84:2003;517-527.
3. Brown G., Rixon H.W., Sugrue R.J. Respiratory Syncytial Virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1. J. Gen. Virol. 83(8):2002;1841-1850.
4. Bucher D.J., Kharitonenkow L.G., Zakomiridin J.A., Grivoriev V.B., Klimenko S.M., Davis J.F. Incorporation of influenza M protein into liposomes. J. Virol. 36:1980;586-590.
5. Cox J.C., Hampson A.W., Hamilton R.C. An immunofluorescence study of influenza virus filament formation. Arch. Virol. 63:1980;275-284.
6. Gomez-Puertas P., Albo C., Perez-Pastrana E., Vivo A., Portela A. Influenza virus matrix protein is the major driving force in virus budding. J. Virol. 74(24):2000;11538-11547.
7. Harris A., Forouhar F., Qui S., Sha B., Luo M. The crystal structure of the influenza matrix protein M1 at neutral pH: M1-M1 protein interfaces can rotate in the oligomeric structures of M1. Virology. 289:2001;34-44.
8. Hui E.K.-W., Barman S., Yang T.Y., Nayak D.P. Basic residues of the helix six domain of influenza virus M1 involved in nuclear translocation of M1 can be replaced by PTAP and YPDL late assembly domain motifs. J. Virol. 77(12):2003;7078-7092.
9. Inglis S.C., Brown C.M. Spliced and unspliced RNAs encoded by virion RNA segment 7 of influenza virus. Nucleic Acids Res. 9:1981;2727-2740.
10. Jackson D., Cadman A., Zurcher T., Barclay W.S. A reverse genetics approach for recovery of recombinant influenza B viruses from cDNA. J. Virol. 76(22):2002;11744-11747.
11. Jin H., Pleser G., Zhang J., Lamb R.A. Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J. 16(6):1997;1236-1247.
12. Lamb R.A., Choppin P.W. Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. Virology. 112:1981;729-737.
13. Latham T., Galarza J.M. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J. Virol. 75(13):2001;6154-6165.
14. Liu T., Muller J., Ye Z. Association of influenza virus matrix protein with ribonucleoproteins may control viral growth and morphology. Virology. 304:2002;88-96.
15. Mitnaul L.J., Castrucci K.G., Murti K.G., Kawaoka Y. The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication. J. Virol. 74:1996;8709-8719.
16. Neumann G., Watanabe T., Ito H., Watanabe S., Goto G., Gao P., Hughes M., Perez D., Donis R., Hoffmann E., Hobom G. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. 96:1999;9345-9350.
17. Roberts P.C., Compans R.W. Host cell dependence of viral morphology. Proc. Natl. Acad. Sci. 95:1998;5746-5751.
18. Roberts P.C., Lamb R.A., Compans R.W. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology. 240:1998;127-137.
19. Sha B., Luo M. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat. Struct. Biol. 4(3):1997;239-244.
20. Simpson-Holley M., Ellis D., Fisher D., Macauley J., Digard P. A functional link between the actin cytoskeleton and lipid rafts during budding of filamentous influenza virions. Virology. 2002;212-225.
21. Smirnov Yu.A., Kuznetsova M.A., Kaverin N.V. The genetic aspects of influenza virus filamentous particle formation. Arch. Virol. 118:1991;279-284.
22. Wakefield L., Brownlee G. RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Res. 17:1989;8569-8580.
23. Ward A.C. Specific changes in the M1 protein during adaptation of influenza virus to mouse. Arch. Virol. 140(2):1995;383-389.
24. Yao Q., Compans R.W. Filamentous particle formation by human parainfluenza virus type 2. J. Gen. Virol. 81(5):2000;1305-1312.
25. Yasuda J., Toyoda M., Nakayama M., Ishihama A. Regulatory effects of matrix protein variations on influenza virus growth. Arch. Virol. 133:1993;283-294.
26. Yasuda J., Bucher D., Ishihama A. Growth control of influenza A virus by M1 protein: analysis of transfectant viruses carrying the chimeric M gene. J. Virol. 68:1994;8141-8146.
27. Zebedee S.L., Lamb R.A. Influenza A virus M2 protein-monoclonal antibody restriction of virus growth and detection of M2 in virions. J. Virol. 62:1988;2762-2772.
28. Zebedee S.L., Lamb R.A. Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Proc. Natl. Acad. Sci. U.S.A. 86:1989;1061-1065.